pharma · Asthma · Type 2 Diabetes
AstraZeneca
AstraZeneca clinical programs — 20 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridgeshire CB2 0AA, GB
- Employees
- 79,242
- Programs
- 129
- Drugs
- 77
- Patents
- 25
AstraZeneca projects
20 ClinicalTrials.gov programs sponsored by AstraZeneca.
AstraZeneca has 20 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
AZD0292
AstraZeneca
Bronchiectasis With Pseudomonas Aeruginosa Colonization
1 trial -
AZD2265 (FPI-2265)
AstraZeneca
Metastatic Prostate Cancer
1 trial -
AZD2281
AstraZeneca
Ovarian Neoplasms
1 trial -
AZD5363 when combined with weekly paclitaxel.
AstraZeneca
Advanced or Metastatic Breast Cancer
1 trial -
AZD6793
AstraZeneca
Chronic Obstructive Pulmonary Disease (COPD)
1 trial -
AZD8931
AstraZeneca
Neoplasms
1 trial -
AZD9668
AstraZeneca
Chronic Obstructive Pulmonary Disease
1 trial -
Atuliflapon
AstraZeneca
Asthma
1 trial -
Calquence 100 mg film-coated tablets
AstraZeneca
mantle cell lymphoma (MCL)
1 trial -
D6405C00002
AstraZeneca
Chronic Kidney Disease
1 trial -
Fostamatinib
AstraZeneca
Rheumatoid Arthritis
1 trial -
Gefitinib
AstraZeneca
Head and Neck Cancer
1 trial -
MEDI4736
AstraZeneca
Recurrent or Metastatic PD-L1-positive Squamous Cell Carcinoma of the Head and Neck
1 trial -
Olaparib Continuous (28-Day cycle) 300 mg BD.
AstraZeneca
Metastatic Triple Negative Breast Cancer
1 trial -
Osimertinib + Savolitinib
AstraZeneca
Non-Small Cell Lung Cancer
1 trial -
Osimertinib 80 mg/40 mg
AstraZeneca
Stage II-IIIB Non-small Cell Lung Carcinoma
1 trial -
Tozorakimab
AstraZeneca
Asthma
1 trial -
Trastuzumab deruxtecan
AstraZeneca
Advanced Solid Tumors With HER2 Mutation,eg:Colorectal,Urothelial,Gastric, Hepatobiliary,Endometrial,Melanoma,Ovarian,Cervical,Salivary Gland,Pancreatic,Breast
1 trial -
Volrustomig
AstraZeneca
Sub-study 1 Cervical Cancer (Volrustomig Monotherapy)
1 trial -
osimertinib
AstraZeneca
Carcinoma
1 trial
Frequently asked questions
How many clinical projects does AstraZeneca have?
20 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.